Neurocrine Bioscience buy Guggenheim
Start price
31.07.26
/
50%
€144.40
Target price
31.07.27
€192.87
Performance (%)
-8.97%
Price
11:33
€131.45
Summary
This prediction is currently active. With a performance of -8.97%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 31.07.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Neurocrine Bioscience | -1.951% |
| iShares Core DAX® | -1.059% |
| iShares Nasdaq 100 | -2.387% |
| iShares Nikkei 225® | -4.361% |
| iShares S&P 500 | -1.778% |
Comments by Guggenheim for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Guggenheim from $200.00 to $222.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Guggenheim for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€157.15
21.07.26
21.07.26
€175.28
21.07.27
21.07.27
-16.35%
11:33
11:33
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.15
06.05.26
06.05.26
€149.31
06.05.27
06.05.27
6.74%
11:33
11:33
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€108.15
06.05.25
06.05.25
€146.09
06.05.26
06.05.26
14.56%
07.05.26
07.05.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€120.00
10.02.25
10.02.25
€157.98
10.02.26
10.02.26
-2.54%
11.02.26
11.02.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€140.30
02.08.24
02.08.24
€164.90
02.08.25
02.08.25
-21.03%
03.08.25
03.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€131.25
02.05.24
02.05.24
€158.42
02.05.25
02.05.25
-26.05%
03.05.25
03.05.25